Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial

  1. Polizzotto, M.N.
  2. Nordwall, J.
  3. Babiker, A.G.
  4. Phillips, A.
  5. Vock, D.M.
  6. Eriobu, N.
  7. Kwaghe, V.
  8. Paredes, R.
  9. Mateu, L.
  10. Ramachandruni, S.
  11. Narang, R.
  12. Jain, M.K.
  13. Lazarte, S.M.
  14. Baker, J.V.
  15. Frosch, A.E.P.
  16. Poulakou, G.
  17. Syrigos, K.N.
  18. Arnoczy, G.S.
  19. McBride, N.A.
  20. Robinson, P.A.
  21. Sarafian, F.
  22. Bhagani, S.
  23. Taha, H.S.
  24. Benfield, T.
  25. Liu, S.T.H.
  26. Antoniadou, A.
  27. Jensen, J.U.S.
  28. Kalomenidis, I.
  29. Susilo, A.
  30. Hariadi, P.
  31. Jensen MD, T.O.
  32. Morales-Rull, J.L.
  33. Helleberg, M.
  34. Meegada, S.
  35. Johansen, I.S.
  36. Canario, D.
  37. Fernández-Cruz, E.
  38. Metallidis, S.
  39. Shah, A.
  40. Sakurai, A.
  41. Koulouris, N.G.
  42. Trotman, R.
  43. Weintrob, A.C.
  44. Podlekareva, D.
  45. Hadi, U.
  46. Lloyd, K.M.
  47. Røge, B.T.
  48. Saito, S.
  49. Sweerus, K.
  50. Malin, J.J.
  51. Lübbert, C.
  52. Muñoz, J.
  53. Cummings, M.J.
  54. Losso, M.H.
  55. Turner, D.
  56. Shaw-Saliba, K.
  57. Dewar, R.
  58. Highbarger, H.
  59. Lallemand, P.
  60. Rehman, T.
  61. Gerry, N.
  62. Arlinda, D.
  63. Chang, C.C.
  64. Grund, B.
  65. Holbrook, M.R.
  66. Holley, H.P.
  67. Hudson, F.
  68. McNay, L.A.
  69. Murray, D.D.
  70. Pett, S.L.
  71. Shaughnessy, M.
  72. Smolskis, M.C.
  73. Touloumi, G.
  74. Wright, M.E.
  75. Doyle, M.K.
  76. Popik, S.
  77. Hall, C.
  78. Ramanathan, R.
  79. Cao, H.
  80. Mondou, E.
  81. Willis, T.
  82. Thakuria, J.V.
  83. Yel, L.
  84. Higgs, E.
  85. Kan, V.L.
  86. Lundgren, J.D.
  87. Neaton, J.D.
  88. Lane, H.C.
  89. Show all authors +
Journal:
The Lancet

ISSN: 1474-547X 0140-6736

Year of publication: 2022

Volume: 399

Issue: 10324

Pages: 530-540

Type: Article

DOI: 10.1016/S0140-6736(22)00101-5 GOOGLE SCHOLAR lock_openOpen access editor